Behavioral
Ella E M Brown Charitable Circle
Ella E M Brown Charitable Circle was paid $13.80M by Medicaid between Jan 2018 and Dec 2024, across 187 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoELLA E M BROWN CHARITABLE CIRCLE
MARSHALL, MI 49068
MARSHALL, MI 49068
33aNPI1366591794assigned 01/08/2007
33bProvider typePsychologist
28Total paid$13.80M
24GClaims693,009
24DCodes billed187
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychologist providers in Michigan
Rank by total paid#6 of 105
Median peer was paid$113K
This provider vs. median123×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,130 | $1.33M | |
| 2019 | 88,401 | $1.42M | |
| 2020 | 75,244 | $1.28M | |
| 2021 | 101,577 | $2.03M | |
| 2022 | 110,353 | $2.26M | |
| 2023 | 123,922 | $2.74M | |
| 2024incomplete | 112,382 | $2.75M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 74,749 | 67,691 | $3.77M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 45,917 | 42,920 | $3.34M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.9% | 11,074 | 10,889 | $675K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 6,967 | 6,850 | $647K |
| 59426 | 4.0% | 645 | 641 | $555K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 6,838 | 6,454 | $440K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 2.7% | 534 | 529 | $374K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 4,454 | 4,409 | $343K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 8,719 | 8,463 | $259K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.8% | 2,987 | 2,970 | $242K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.7% | 2,652 | 2,642 | $241K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 6,102 | 5,932 | $238K |
175 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 2,475 | $188K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 2,669 | $174K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.2% | 1,656 | $165K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.1% | 7,618 | $148K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,692 | $137K |
| 59430 | <1% | 617 | $131K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12,442 | $126K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,905 | $116K |
| 99460 | <1% | 2,097 | $112K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,359 | $96K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,239 | $93K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,110 | $85K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,207 | $83K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,127 | $82K |
| 20610 | <1% | 2,062 | $72K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 406 | $56K |
| 43248 | <1% | 718 | $49K | |
| 90715 | <1% | 2,043 | $48K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 270 | $46K |
| 90682 | <1% | 595 | $34K | |
| 90686 | <1% | 3,683 | $33K | |
| 54150 | <1% | 553 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,176 | $28K |
| 90651 | <1% | 806 | $27K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,345 | $27K |
| 92557 | <1% | 1,256 | $26K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,130 | $24K |
| 96127 | <1% | 8,031 | $20K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 489 | $20K |
| 81025 | <1% | 2,981 | $19K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 339 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,244 | $16K |
| 99441 | <1% | 794 | $16K | |
| 92567 | <1% | 1,772 | $16K | |
| 87634 | <1% | 376 | $15K | |
| 99442 | <1% | 423 | $15K | |
| 90473 | <1% | 2,147 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,112 | $15K |
| 99462 | <1% | 620 | $14K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 108 | $14K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 809 | $12K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,756 | $12K |
| 59425 | <1% | 26 | $11K | |
| 81003 | <1% | 6,020 | $10K | |
| 99205 | Prolong outpt/office vis | <1% | 81 | $10K |
| 99051 | <1% | 5,918 | $9K | |
| 98966 | <1% | 3,524 | $9K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 810 | $8K |
| 90677 | <1% | 664 | $8K | |
| 90670 | <1% | 3,350 | $8K | |
| 99218 | <1% | 145 | $8K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 271 | $7K |
| 59514 | <1% | 21 | $7K | |
| 90621 | <1% | 296 | $7K | |
| 83655 | <1% | 592 | $7K | |
| 90632 | <1% | 122 | $7K | |
| 73564 | <1% | 265 | $7K | |
| 90746 | <1% | 97 | $5K | |
| 69210 | <1% | 209 | $5K | |
| 99385 | <1% | 53 | $5K | |
| 59025 | Fetal non-stress test | <1% | 168 | $5K |
| 90707 | <1% | 780 | $4K | |
| 90673 | <1% | 54 | $4K | |
| 99383 | <1% | 42 | $4K | |
| 99443 | <1% | 56 | $3K | |
| 64635 | <1% | 17 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 534 | $2K |
| 99221 | <1% | 41 | $2K | |
| 99406 | <1% | 325 | $2K | |
| 58300 | <1% | 48 | $2K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,094 | $2K |
| 94010 | <1% | 128 | $2K | |
| 64636 | <1% | 17 | $2K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 157 | $2K |
| 31231 | <1% | 15 | $2K | |
| 90734 | <1% | 292 | $2K | |
| 91320 | <1% | 14 | $2K | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 33 | $1K |
| 90656 | <1% | 157 | $1K | |
| 73030 | <1% | 80 | $1K | |
| 93016 | <1% | 112 | $1K | |
| 92552 | <1% | 76 | $1K | |
| 93000 | <1% | 167 | $1K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 37 | $1K |
| 90480 | <1% | 42 | $1K | |
| 99382 | <1% | 14 | $1K | |
| 85018 | <1% | 660 | $1K | |
| 99459 | <1% | 85 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 830 | $1K |
| 90716 | <1% | 653 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 15 | $1K |
| 73100 | <1% | 61 | $1K | |
| 93018 | <1% | 112 | $892.07 | |
| 17110 | <1% | 13 | $819.00 | |
| 11982 | <1% | 12 | $713.19 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 610 | $712.01 |
| 69209 | <1% | 68 | $659.34 | |
| 98925 | <1% | 37 | $658.13 | |
| 94726 | <1% | 95 | $642.72 | |
| 87807 | <1% | 63 | $580.49 | |
| 90474 | <1% | 85 | $566.18 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 87 | $498.30 |
| 98967 | <1% | 121 | $483.79 | |
| 94729 | <1% | 96 | $482.73 | |
| 73130 | <1% | 20 | $424.67 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 83 | $420.33 |
| 95251 | <1% | 25 | $418.62 | |
| 99000 | <1% | 37 | $362.35 | |
| 99407 | <1% | 21 | $306.83 | |
| 73502 | <1% | 12 | $301.75 | |
| 90658 | <1% | 36 | $259.04 | |
| 96161 | <1% | 169 | $179.61 | |
| 94060 | <1% | 25 | $172.93 | |
| 82962 | <1% | 73 | $166.58 | |
| 90619 | <1% | 202 | $156.84 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 30 | $150.48 |
| 92587 | <1% | 12 | $135.45 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 26 | $133.13 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 36 | $116.52 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15 | $112.00 |
| G0008 | Administration of influenza virus vaccine | <1% | 50 | $84.96 |
| 99188 | <1% | 12 | $80.38 | |
| 90662 | <1% | 12 | $55.95 | |
| G9002 | Coordinated care fee, maintenance rate | <1% | 33 | $40.52 |
| 36416 | <1% | 13 | $38.40 | |
| 1003F | <1% | 51,359 | $28.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 54 | $28.52 |
| 1160F | <1% | 92,087 | $17.89 | |
| 1111F | <1% | 1,852 | $17.50 | |
| 1033F | <1% | 43,056 | $12.43 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $12.33 |
| 3016F | <1% | 51,106 | $6.46 | |
| 1220F | <1% | 20,818 | $5.95 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 191 | $1.05 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $0.75 |
| 1036F | <1% | 50,029 | $0.53 | |
| 1034F | 0% | 20,689 | $0.00 | |
| 4000F | 0% | 5,376 | $0.00 | |
| 99024 | 0% | 5,653 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 2,335 | $0.00 |
| 3044F | 0% | 1,130 | $0.00 | |
| 90680 | 0% | 2,723 | $0.00 | |
| 90698 | 0% | 3,712 | $0.00 | |
| 1031F | 0% | 16,139 | $0.00 | |
| 90696 | 0% | 268 | $0.00 | |
| 3075F | 0% | 127 | $0.00 | |
| 90744 | 0% | 2,102 | $0.00 | |
| 3079F | 0% | 340 | $0.00 | |
| 1101F | 0% | 343 | $0.00 | |
| G9226 | Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) | 0% | 378 | $0.00 |
| 0503F | 0% | 541 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 254 | $0.00 |
| 3080F | 0% | 141 | $0.00 | |
| 1123F | 0% | 199 | $0.00 | |
| 3074F | 0% | 755 | $0.00 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 43 | $0.00 |
| 1035F | 0% | 24 | $0.00 | |
| 2028F | 0% | 1,132 | $0.00 | |
| 3078F | 0% | 590 | $0.00 | |
| 1032F | 0% | 7,437 | $0.00 | |
| 90700 | 0% | 41 | $0.00 | |
| 90633 | 0% | 1,886 | $0.00 | |
| 99173 | 0% | 298 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 7,865 | $0.00 |
| 3077F | 0% | 169 | $0.00 | |
| 1100F | 0% | 291 | $0.00 | |
| 90685 | 0% | 206 | $0.00 | |
| 3046F | 0% | 51 | $0.00 | |
| 90710 | 0% | 351 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 26 | $0.00 |
| 3051F | 0% | 70 | $0.00 | |
| 0502F | 0% | 162 | $0.00 | |
| 99408 | 0% | 21 | $0.00 | |
| 1124F | 0% | 42 | $0.00 | |
| 3045F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOOLE, ANDREW (CFO)